Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice
Open Access
- 13 September 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 15 (9), e0009785
- https://doi.org/10.1371/journal.pntd.0009785
Abstract
Rift Valley fever virus (RVFV) is a mosquito-borne bunyavirus with a wide host range including ruminants and humans. RVFV outbreaks have had devastating effects on public health and the livestock industry in African countries. However, there is no approved RVFV vaccine for human use in non-endemic countries and no FDA-approved antiviral drug for RVFV treatment. The RVFV 78kDa protein (P78), which is a membrane glycoprotein, plays a role in virus dissemination in the mosquito host, but its biological role in mammalian hosts remains unknown. We generated an attenuated RVFV MP-12 strain-derived P78-High virus and a virulent ZH501 strain-derived ZH501-P78-High virus, both of which expressed a higher level of P78 and carried higher levels of P78 in the virion compared to their parental viruses. We also generated another MP-12-derived mutant virus (P78-KO virus) that does not express P78. MP-12 and P78-KO virus replicated to similar levels in fibroblast cell lines and Huh7 cells, while P78-High virus replicated better than MP-12 in Vero E6 cells, fibroblast cell lines, and Huh7 cells. Notably, P78-High virus and P78-KO virus replicated less efficiently and more efficiently, respectively, than MP-12 in macrophage cell lines. ZH501-P78-High virus also replicated poorly in macrophage cell lines. Our data further suggest that inefficient binding of P78-High virus to the cells led to inefficient virus internalization, low virus infectivity and reduced virus replication in a macrophage cell line. P78-High virus and P78-KO virus showed lower and higher virulence than MP-12, respectively, in young mice. ZH501-P78-High virus also exhibited lower virulence than ZH501 in mice. These data suggest that high levels of P78 expression attenuate RVFV virulence by preventing efficient virus replication in macrophages. Genetic alteration leading to increased P78 expression may serve as a novel strategy for the attenuation of RVFV virulence and generation of safe RVFV vaccines.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI127984)
- National Institute of Allergy and Infectious Diseases (AI148763)
This publication has 52 references indexed in Scilit:
- Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion ProteinJournal of Virology, 2012
- Heparan Sulfate Facilitates Rift Valley Fever Virus Entry into the CellJournal of Virology, 2012
- Tissue Tropism and Target Cells of NSs-Deleted Rift Valley Fever Virus in Live Immunodeficient MicePLoS Neglected Tropical Diseases, 2011
- A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challengeVirology, 2010
- Single-particle cryo-electron microscopy of Rift Valley fever virusVirology, 2009
- Electron Cryo-Microscopy and Single-Particle Averaging of Rift Valley Fever Virus: Evidence for G N -G C Glycoprotein HeterodimersJournal of Virology, 2009
- Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron TomographyJournal of Virology, 2008
- NSm and 78-Kilodalton Proteins of Rift Valley Fever Virus Are Nonessential for Viral Replication in Cell CultureJournal of Virology, 2006
- Rescue of Infectious Rift Valley Fever Virus Entirely from cDNA, Analysis of Virus Lacking the NSs Gene, and Expression of a Foreign GeneJournal of Virology, 2006
- Mutagen-directed Attenuation of Rift Valley Fever Virus as a Method for Vaccine DevelopmentJournal of General Virology, 1985